These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Comparison of the anticonvulsant efficacies and neurotoxic effects of valproic acid, phenytoin, and the ketogenic diet. Bough KJ, Eagles DA. Epilepsia; 2001 Oct; 42(10):1345-53. PubMed ID: 11737171 [Abstract] [Full Text] [Related]
31. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Luszczki JJ, Cioczek JD, Kocharov SL, Andres-Mach M, Kominek M, Zolkowska D. Eur J Pharmacol; 2010 Dec 01; 648(1-3):74-9. PubMed ID: 20826140 [Abstract] [Full Text] [Related]
33. Selection of phenytoin responders and nonresponders in male and female amygdala-kindled Sprague-Dawley rats. Löscher W, Cramer S, Ebert U. Epilepsia; 1998 Nov 01; 39(11):1138-47. PubMed ID: 9821977 [Abstract] [Full Text] [Related]
37. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists. Sadek B, Saad A, Schwed JS, Weizel L, Walter M, Stark H. Drug Des Devel Ther; 2016 Nov 01; 10():3633-3651. PubMed ID: 27853355 [Abstract] [Full Text] [Related]
39. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Luszczki JJ, Mohamed M, Czuczwar SJ. Eur J Pharmacol; 2006 Feb 15; 531(1-3):66-73. PubMed ID: 16403497 [Abstract] [Full Text] [Related]
40. Ralitoline: a reevaluation of anticonvulsant profile and determination of "active" plasma concentrations in comparison with prototype antiepileptic drugs in mice. Löscher W, von Hodenberg A, Nolting B, Fassbender CP, Taylor C. Epilepsia; 1991 Feb 15; 32(4):560-8. PubMed ID: 1868813 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]